Allurion Closes Offering and Private Placement to Advance GLP-1 Pipeline Allurion Technologies, Inc. (NYSE: ALUR), a company focused on ending obesity, announced the successful closing of its previously announced registered direct offering. The offering involved institutional investors purchasing 900,000 shares…
NextGen Healthcare Selected by Elite DNA to Improve Patient and Staff Experiences NextGen Healthcare, a top provider of innovative healthcare technology, has been selected by Elite DNA Behavioral Health, based in Florida, to deliver a scalable platform that will support…
CareDx Study Shows AlloSeq cfDNA Accurately Detects Organ Rejection CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine for transplant patients, announced new findings published in Transplant International. The study demonstrated that the performance of AlloSeq™ cfDNA in detecting allograft…
Phase 2 Trial Begins for Early Alzheimer’s with Sinaptica’s Neuromodulation System Sinaptica Therapeutics, Inc., a clinical-stage company focused on developing personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced the launch of a Phase 2 clinical trial for…
Variational AI Raises $5.5 Million to Launch Foundation Model for Drug Discovery Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, has successfully closed its oversubscribed $5.5 million Seed extension round. Enki™ is designed…
OS Therapies Granted Patent for OST-HER2 Commercial Manufacturing OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company focused on immunotherapies and targeted drug conjugates for cancer treatment, announced today that it has received a Notice of Allowance from the United…
Shape Memory Medical Begins European Enrollment in AAA-SHAPE Trial Shape Memory Medical Inc., a developer of custom shape memory polymers for endovascular markets, has announced the first European enrollment in the AAA-SHAPE Pivotal Trial. This prospective, multicenter, randomized, open-label trial…
DIA Europe 2025 to Tackle EU Reforms & Global Healthcare Harmonization DIA, a global non-profit for life sciences professionals, will host DIA Europe 2025 from March 18-20 in Basel, bringing together stakeholders to discuss healthcare system efficiencies, international collaboration, and…
Stablepharma Secures €2.5M EIC Grant, Among Top 71 EU Innovators UK biotech Stablepharma Ltd has secured a €2.5M grant from the European Innovation Council (EIC) Accelerator Programme. The funding acknowledges its innovative refrigeration-free pharmaceutical technology, meeting the EIC’s high standards…
DocGo Expands into Chattanooga Region in Collaboration with Major Tennessee Healthcare System DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has extended its contract with a…
Stablepharma Secures €2.5M EIC Grant, Named Top EU Innovator UK-based biotechnology firm Stablepharma Ltd has been awarded €2.5 million through the prestigious European Innovation Council (EIC) Accelerator program. The grant recognises the company’s cutting-edge fridge-free pharmaceutical technology, which meets EIC’s…
Precision BioSciences Announces Early Safety and Antiviral Results for PBGENE-HBV in ELIMINATE-B Trial Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases,…